全球腦瘤診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計腦瘤診斷市場將從 2025 年的 24.1 億美元成長到 2034 年的 41.3 億美元，2026 年至 2034 年的複合年成長率為 6.17%。

由於腦腫瘤發生率不斷上升以及診斷影像技術的進步，全球腦腫瘤診斷市場正穩步成長。早期準確診斷對於制定有效的治療方案至關重要。磁振造影（MRI）、電腦斷層掃描）和分子診斷檢測的廣泛應用推動了市場成長。人們對神經系統疾病的認知不斷提高以及醫療保健服務的改善也進一步促進了市場需求的成長。

關鍵成長要素包括基於生物標記的檢測技術和精準醫療方法的進步。醫療服務提供者正在投資高解析度成像和人工智慧輔助診斷工具，以提高檢測準確率。腫瘤學領域的研究拓展和政府資助也推動了市場成長。此外，人口老化導致發病率上升，進而推高了對診斷的需求。

隨著非侵入性診斷技術的不斷進步，未來前景依然強勁。新興市場正在發展醫療基礎設施，這為市場成長提供了機會。人工智慧與影像分析的融合將提升早期檢測能力。隨著個人化癌症治療的興起，全球腦腫瘤診斷市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球腦腫瘤診斷市場：依診斷技術分類

• 市場分析、洞察與預測
• 醫學影像技術
• 組織取樣/切片檢查
• 分子診斷
• 其他

第5章 全球腦腫瘤診斷市場：依腦腫瘤類型分類

• 市場分析、洞察與預測
• 膠質瘤
• 腦膜瘤
• 腦下垂體瘤
• 其他

第6章 全球腦腫瘤診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診斷檢查室
• 癌症醫院和中心

第7章 全球腦腫瘤診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Abbott Laboratories
  • Illumina Inc
  • Hologic Inc
  • Agilent Technologies
  • Bio-Rad Laboratories

The Brain Cancer Diagnostics Market size is expected to reach USD 4.13 Billion in 2034 from USD 2.41 Billion (2025) growing at a CAGR of 6.17% during 2026-2034.

The Global Brain Cancer Diagnostics Market is growing steadily due to rising prevalence of brain tumors and advancements in diagnostic imaging technologies. Early and accurate diagnosis is crucial for effective treatment planning. Increasing adoption of MRI, CT scans, and molecular diagnostic tests is supporting market expansion. Growing awareness about neurological disorders and improved healthcare access are further driving demand.

Major growth drivers include advancements in biomarker-based testing and precision medicine approaches. Healthcare providers are investing in high-resolution imaging and AI-assisted diagnostic tools to enhance detection accuracy. Expanding research in oncology and supportive government funding are also strengthening market growth. Additionally, increasing geriatric populations are contributing to higher incidence rates, boosting diagnostic demand.

Future prospects remain strong as innovations in non-invasive diagnostic techniques continue to evolve. Emerging markets upgrading healthcare infrastructure will present growth opportunities. Integration of artificial intelligence in imaging analysis will enhance early detection capabilities. As personalized oncology gains momentum, the Global Brain Cancer Diagnostics Market is expected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Diagnostic Technique

• Imaging Techniques
• Tissue Sampling/Biopsy
• Molecular Diagnostics
• Others

By Brain Cancer Type

• Gliomas
• Meningiomas
• Pituitary Tumors
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Cancer Hospitals/Centers

COMPANIES PROFILED

• GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Illumina Inc, Hologic Inc, Agilent Technologies, BioRad Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY DIAGNOSTIC TECHNIQUE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Diagnostic Technique
• 4.2. Imaging Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tissue Sampling/Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY BRAIN CANCER TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Brain Cancer Type
• 5.2. Gliomas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Meningiomas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Pituitary Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cancer Hospitals/Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Diagnostic Technique
  • 7.2.2 By Brain Cancer Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Diagnostic Technique
  • 7.3.2 By Brain Cancer Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Diagnostic Technique
  • 7.4.2 By Brain Cancer Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Diagnostic Technique
  • 7.5.2 By Brain Cancer Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Diagnostic Technique
  • 7.6.2 By Brain Cancer Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BRAIN CANCER DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GE Healthcare
  • 9.2.2 Siemens Healthineers
  • 9.2.3 Philips Healthcare
  • 9.2.4 Thermo Fisher Scientific
  • 9.2.5 Roche Diagnostics
  • 9.2.6 Abbott Laboratories
  • 9.2.7 Illumina Inc
  • 9.2.8 Hologic Inc
  • 9.2.9 Agilent Technologies
  • 9.2.10 Bio-Rad Laboratories